Module 9
Ketamine: Client Screening and Harm Reduction
Module Description
The focus for Module 3 will be on how to use this knowledge to educate clients and obtain informed consent. We will be looking at expected and possible adverse effects (according to the dose range), contraindications, and concomitant medications. We will also be looking at the important role of harm reduction when working with clients in a ketamine-assisted therapy setting. Finally, we will be looking at some key considerations to mention to the client before obtaining consent.
Module Description
The focus for Module 3 will be on how to use this knowledge to educate clients and obtain informed consent. We will be looking at expected and possible adverse effects (according to the dose range), contraindications, and concomitant medications. We will also be looking at the important role of harm reduction when working with clients in a ketamine-assisted therapy setting. Finally, we will be looking at some key considerations to mention to the client before obtaining consent.
Learning Outcomes
Upon successful completion of the course, you will be able to:
-
Explain the risks, benefits, and pharmacological knowledge of ketamine in plain language to interdisciplinary colleagues and to clients as part of the informed consent process.
-
Describe the subjective and physiological effects and adverse effects of ketamine according to different dose ranges as they relate to psychedelic-assisted therapy.
-
Describe the contraindications and concomitant medications of ketamine in order to determine client suitability for psychedelic-assisted therapy.
-
Identify models of substance use and potential for addiction.